~~<i id='A5629927B0'><strike id='A5629927B0'><tt id='A5629927B0'><pre id='A5629927B0'></pre></tt></strike></i>~~

Home» explore» entertainment

entertainment

author：hotspot 2025-09-29 04:06:02 Page View：124

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Nobel honors Karikó and Weissman's enduring partnership
Next article： Heart attack and stroke risk calculators need revising

comprehensive

George Santos makes 1st court appearance after pleading not guilty to 13 counts

1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

6 solutions to address cancer drug shortages and others

GeorgeFrey/GettyImagesWASHINGTON—RepublicansandDemocratsalikewanttostopdrugshortagesfromhappening.Th

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

European officials brace for rough respiratory virus season

FinnbarrWebster/GettyImagesLONDON—HealthofficialsintheU.K.andEuropearerampinguptheircampaignsurginge